Quantcast

NORTHERN CALIFORNIA RECORD

Friday, November 22, 2024

Class-action suit filed over Premiere Nutrition Corp.'s claims for Joint Juice supplements

General court 09

shutterstock.com

SAN FRANCISCO – An Illinois consumer claims that an Emeryville company's joint health supplements are falsely advertised.

Sandra Dent filed a complaint individually and on behalf of all others similarly situated on Nov. 21 in the U.S. District Court for the Northern District of California against Premiere Nutrition Corp., formerly known as Joint Juice Inc., alleging that the supplement manufacturer obtained profit through unfair or deceptive trade or commerce.

According to the complaint, the plaintiffs allege that she was enticed to purchase defendant's Joint Juice product, which promises to help support and nourish cartilage, lubricate joints and improve joint comfort without any limitation on which joints for adults of all ages. The suit states that despite defendant’s representations, meta-analysis studies conclude that glucosamine, alone or with chondroitin sulfate, is not effective in providing the represented joint health benefits.

The plaintiffs hold Premiere Nutrition Corp. responsible because the defendant allegedly failed to provide its promised health benefits and deceived consumers into paying for deceptive products at premium prices.

The plaintiff requests a trial by jury and seeks judgment in her favor; declare the case as a class action; designate class representative and class counsel; actual, punitive and statutory damages; injunctive relief; attorneys’ fees; litigation costs; interest and further relief as may be just. She is represented by Timothy G. Blood, Leslie E. Hurst and Thomas J. O'Reardon II of Blood Hurst & O'Reardon LLP in San Diego, Todd D. Carpenter of Carlson Lynch Sweet Kilpela & Carpenter LLP in San Diego, Adam J. Levitt and Edmund S. Aronowitz of Grant & Eisenhofer PA in Chicago and Joseph J. Siprut of Siprut PC in Chicago.

U.S. District Court for the Northern District of California Case number 3:16-cv-06721

More News